A winning synergy for managing Type II diabetes
Diabetes — increasingly common, especially among women and older adults — exists in two main forms: Type 1, due to autoimmune dysfunction; and Type 2 (mellitus), from poor insulin production or tissue insulin resistance. About 90% of diabetics have Type 2 diabetes, which, untreated, leads to vascular damage, atherosclerosis, heart attack, retinal and kidney issues.
Given its prevalence, research has focused on safe ways to control it. Two natural hypoglycemic agents stand out: Morus alba (white mulberry) bud extract and D-chiro-inositol, a carbohydrate synthesized from glucose but often deficient in insulin-resistant individuals.
Glauber Pharma’s supplement MELITO combines Morus alba (standardized 1% 1-DNJ) with D-chiro-inositol for amplified effect. Tested on Drosophila (fruit flies) induced with Type 2 diabetes via a 10% sugar diet, the combination lowered glucose levels significantly — proving its synergistic action.
It uses standardized botanical extracts to naturally support balanced glycemia, complementing a healthy diet and lifestyle. Morus alba provides a full phytochemical spectrum; D-chiro-inositol activates insulin receptors. Sustained-release tablets ensure gradual absorption over 4 hours for steady glycemic control — an effective, natural aid for Type 2 and gestational diabetes. Available in pharmacies and qualified herbal stores.